GSK Stockmann

GSK Stockmann has advised the shareholders of Beams Technology GmbH, Berlin, Germany, on their divestment to Insight Partners and Liberty Hall Capital Partners backed Comply365 Group. Comply365 is a leading provider of Operational Content Management, Safety Management and Training Management in the highly regulated industries of aviation, defense, rail and space. Beams has pioneered a Safety AI solution for the aviation industry to automate safety data processing and enable proactive, predictive risk management. The acquisition accelerates Comply365’s investment in the development of an industry-first, AI platform across operations, safety, and training management. More details can be found in the official deal notification. A GSK Stockmann team led by Berlin-based partner Robert Korndörfer advised the Beams shareholders on all legal and tax aspects of the divestment. GSK Stockmann’s M&A/private equity team regularly advises strategic investors and financial sponsors on domestic and cross-border buy-out and exit transactions. It consists of more than 50 lawyers working together seamlessly across our seven offices and all practice areas of GSK Stockmann. Advisers of the shareholders of Beams Technology GmbH at GSK Stockmann: Robert Korndörfer (lead, Partner, Corporate), Daniel Fehling (Partner, Corporate), Stephan Wachsmuth (Local Partner, Tax), Dominik Berka (Local Partner, Tax), Nicole Deparade (Local Partner, Employment), Dr Martin Hossenfelder (Counsel, IP/IT); Clara López Hernando (Senior Associate, Corporate), Raphaela Guderian (Associate, Employment), Katrin Zukovskaja (Associate, Employment) Other advisers: Contact: GSK STOCKMANN Robert Korndörfer Mohrenstraße 42 10117 Berlin T +49 30 203907 - 93 F +49 30 203907-44 [email protected] Press contact: GSK STOCKMANN Christina Holl Karl-Scharnagl-Ring 8 80539 Munich T +49 89 288174-275 F +49 89 288 174-44 [email protected] Willkie Farr & Gallagher for the Comply365 Group GSK Stockmann is a leading independent European corporate law firm. Over 250 professionals advise German and international clients at our locations in Berlin, Frankfurt/M., Hamburg, Heidelberg, Munich, Luxembourg and London. GSK is the law firm of choice for Real Estate and Financial Services. We also have deep-rooted expertise in key sectors including Funds, Capital Markets, Public, Mobility, Energy and Healthcare. For international transactions and projects, we work together with selected reputable law firms abroad. Our advice combines an economic focus with entrepreneurial foresight. That is what is behind: Your perspective. More about us: www.gsk.de

GSK Stockmann provided comprehensive legal advice on the sale of a majority stake in Deutsche Investment Kapitalverwaltung AG and other companies of the Deutsche Investment Group. The buyer is Deutsche Pfandbriefbank AG. The Deutsche Investment Group is a provider of asset and investment solutions for institutional investors in the residential and commercial property sector. The group has around 375 employees across seven locations in Germany and assets under management totalling over 3 billion euros. A GSK Stockmann team led by Hamburg-based partners Dennis Stenzel and Andreas Peters provided comprehensive advice on the sale. While advising on the transaction, the team was able to draw on one of GSK Stockmann’s core strengths, namely the seamless integration of corporate law expertise and regulatory knowledge across different teams and locations. Deutsche Pfandbriefbank AG (pbb), a leading European bank specialising in commercial real estate finance, is acquiring 89.9% of the regulated Deutsche Investment Kapitalverwaltung AG as well as other companies and majority shareholdings of the Deutsche Investment Group. The purchase price, including variable components, is in the mid-double-digit million euro range. Subject to customary closing conditions, including the necessary regulatory approvals, the transaction is expected to be completed in the first quarter of 2026. Advisers of the seller at GSK Stockmann: Dennis Stenzel (Real Estate Transactions & Investments), Dr Andreas C. Peters (joint lead, Corporate/M&A), Dr Philipp M. Kuhn (Employment Law); Associates: Lisa Gebhard (Real Estate Transactions & Investments), Marie Bogutzki (Investments & Finance), Sebastian Gerhards (Tax), Dr Johanna Baumann (M&A), Raphaela Guderian, Katrin Zukovskaja (both Employment Law), Louisa Hecker (Investments & Finance) Advisers of Deutsche Pfandbriefbank AG Hengeler Müller (comprehensive legal advice), Gleiss Lutz (employment law); Ritterwald Unternehmensberatung, Hystake Investment Partners. Contact: GSK STOCKMANN Dennis Stenzel/Dr Andreas Peters Neuer Wall 69 20354 Hamburg T +49 40 369703 - 0 F +49 40 369703-44 [email protected]/[email protected] Press contact: GSK STOCKMANN Karl-Scharnagl-Ring 8 80539 Munich T +49 89 288174-275 F +49 89 288 174-44 [email protected] GSK Stockmann is a leading independent European corporate law firm. Over 250 professionals advise German and international clients at our locations in Berlin, Frankfurt/M., Hamburg, Heidelberg, Munich, Luxembourg and London. GSK is the law firm of choice for Real Estate and Financial Services. We also have deep-rooted expertise in key sectors including Funds, Capital Markets, Public, Mobility, Energy and Healthcare. For international transactions and projects, we work together with selected reputable law firms abroad. Our advice combines an economic focus with entrepreneurial foresight. That is what is behind: Your perspective. More about us: www.gsk.de

GSK Stockmann advised the LHI Group, based in Pullach, on extending the regulatory AIFM authorisation of LHI Kapitalverwaltungsgesellschaft mbH. LHI Kapitalverwaltungsgesellschaft mbH has been granted an extension to its financial portfolio management authorisation by the German Federal Financial Supervisory Authority (BaFin), and has increased its capital by two million euros to six million euros. This was accompanied by the merger of LHI Capital Management GmbH into LHI Kapitalverwaltungsgesellschaft mbH. This move enables the LHI Group, one of the most successful providers of investment and asset management services in Germany, to consolidate its investment business into a standalone entity, thereby strengthening its market position among institutional and professional investors. A GSK Stockmann team led by Munich partners Oliver Glück and Andreas Dimmling provided the LHI Group with comprehensive advice on regulatory, corporate and employment law issues in connection with the extension of the authorisation and the strategic realignment of the LHI Group. Advisers of the LHI Group at GSK Stockmann: Dr Oliver Glück (lead, Financial Services), Dr Dominik Stolz (Financial Services), Andreas Dimmling, Christina Lorf (both Corporate), Dr Philipp Kuhn, Raphaela Guderian (both Employment Law) ### [caption id="attachment_50988" align="alignnone" width="300"] GSK München[/caption] Contact: GSK STOCKMANN Dr Oliver Glück Karl-Scharnagl-Ring 8 80539 Munich T +49 89 288174 - 33 F +49 89 288174-44 [email protected] Press contact: GSK STOCKMANN Christina Holl Karl-Scharnagl-Ring 8 80539 Munich T +49 89 288174-275 F +49 89 288 174-44 [email protected] GSK Stockmann is a leading independent European corporate law firm. Over 250 professionals advise German and international clients at our locations in Berlin, Frankfurt/M., Hamburg, Heidelberg, Munich, Luxembourg and London. GSK is the law firm of choice for Real Estate and Financial Services. We also have deep-rooted expertise in key sectors including Funds, Capital Markets, Public, Mobility, Energy and Healthcare. For international transactions and projects, we work together with selected reputable law firms abroad. Our advice combines an economic focus with entrepreneurial foresight. That is what is behind:  Your perspective. More about us: www.gsk.de

In another significant strategic move, GSK Stockmann welcomes Simon Spangler as a new partner as of 1 August 2025. This new addition underlines the firm’s leading position in commercial law and transformation issues and will enhance its range of advisory expertise for national and international clients and projects. Dr Simon Spangler is a renowned expert in German and European antitrust law as well as in the areas of compliance and ESG. He specialises in providing antitrust and distribution law advice to companies in the technology, consumer goods and life sciences sectors. He also provides comprehensive advice on issues relating to the platform economy, private enforcement issues and merger control proceedings at the national and international level. In addition, he has many years of experience in related compliance issues, particularly in ESG compliance and internal investigations, as well as in state aid and subsidy law. Simon Spangler’s wealth of experience and in-depth expertise make him a valuable addition to GSK Stockmann’s Corporate team, where he will work closely with the firm’s IT and AI specialists to set new benchmarks in the field of digital economy and AI solutions and help to accelerate the firm’s growth. Simon Spangler is joining GSK Stockmann from Oppenhoff & Partner, where he has worked in the field of antitrust and state aid law since 2013, becoming a partner in January 2019. He will be accompanied by his colleague Renée Eckruth, who will join GSK Stockmann as a Senior Associate. “We are delighted to be welcoming a recognised expert like Simon Spangler to our team. His expertise and network will be a great asset and support the strategic development of our Corporate team. The addition of this new team ensures that we are now in an even stronger position to continue providing our clients with the best possible support with all kinds of complex matters in the future,” says Dr Justus Jansen, Managing Partner at GSK Stockmann. “Simon Spangler’s impressive range of expertise will be a valuable addition to our Corporate team in Germany, Luxembourg and London. Thanks to his extensive expertise in antitrust law and compliance advice, we can now offer the full scope of services in this area. This enables us to provide real added value to our clients and explore additional areas of advice with significant business development potential. His knowledge and many years of experience will help to strengthen and enhance our Corporate team in the long term,” comments Dr Katy Ritzmann, Head of GSK Stockmann’s Corporate division. Simon Spangler also sees great potential in his new role at GSK Stockmann: “I am very pleased to be able to put my expertise to good use at GSK Stockmann – especially in dynamic, future-oriented fields such as digitalisation and ESG. Together with the experienced team at GSK Stockmann, I am confident that I can provide our clients with bespoke, forward-thinking advice.” Press contact: GSK STOCKMANN Karl-Scharnagl-Ring 8 80539 Munich T +49 89 288174-275 F +49 89 288 174-44 [email protected] GSK Stockmann is a leading independent European corporate law firm. Over 250 professionals advise German and international clients at our locations in Berlin, Frankfurt/M., Hamburg, Heidelberg, Munich, Luxembourg and London. GSK is the law firm of choice for Real Estate and Financial Services. We also have deep-rooted expertise in key sectors including Funds, Capital Markets, Public, Mobility, Energy and Healthcare. For international transactions and projects, we work together with selected reputable law firms abroad. Our advice combines an economic focus with entrepreneurial foresight. That is what is behind: Your perspective. More about us: www.gsk.de

Commercial law firm GSK Stockmann continues the strategic expansion of its Corporate team by welcoming Bernd Graßl as a partner at its Munich office with effect from 1 August 2025. The new addition highlights the firm’s leading position in European commercial law and will enhance its range of advisory expertise for listed companies and international cases, as well as in corporate litigation. Dr Bernd Graßl, formerly a partner at GLNS, has extensive expertise in stock corporation and capital markets law, public M&A and corporate law as well as in stock corporation and capital markets disputes and corporate litigation. His many years of experience and in-depth expertise make him a valuable addition to GSK Stockmann’s growing Corporate team. As a trusted expert in his field, Bernd Graßl will help to further strengthen the firm’s 360-degree advisory approach. This means that clients will benefit from even more comprehensive, customised solutions both in Germany and at GSK Stockmann’s international offices in Luxembourg and London. Bernd Graßl will bring fresh dynamism to the team, particularly when it comes to supporting capital market companies and advising on complex corporate law issues and the particularities of legal disputes involving listed companies. “With Bernd Graßl on board, we are ideally positioned to advise and represent clients in the currently recovering stock market environment. His broad expertise and experience are a valuable addition to our Corporate team, both throughout Germany and internationally,” says Dr Katy Ritzmann, Head of GSK Stockmann’s Corporate division, commenting on the arrival of the new partner. “His proven track record in stock corporation and capital markets law, as well as in IPOs for tech companies, makes him a real asset for our clients and our team. The firm will also benefit greatly from his experience in corporate litigation.” “Bernd Graßl’s expertise will enable us to provide our clients with even more comprehensive and strategic support in complex corporate law disputes,” adds Dr Justus Jansen, Managing Partner at GSK Stockmann. “His expertise complements our existing knowledge perfectly and will help us to continue to strengthen our position in the area of corporate litigation. This will allow us to offer our clients an even broader spectrum of high-quality advice – both here in Germany and internationally.” Bernd Graßl is looking forward to his new role: “GSK Stockmann stands for legal advice of the highest quality, entrepreneurial foresight and a strong international network. I am looking forward to working with a highly motivated team to develop innovative, bespoke solutions for our clients, as well as expanding the firm’s range of services throughout Europe.” Press contact: GSK STOCKMANN Karl-Scharnagl-Ring 8 80539 Munich T +49 89 288174-275 F +49 89 288 174-44 [email protected] GSK Stockmann is a leading independent European corporate law firm. Over 250 professionals advise German and international clients at our locations in Berlin, Frankfurt/M., Hamburg, Heidelberg, Munich, Luxembourg and London. GSK is the law firm of choice for Real Estate and Financial Services. We also have deep-rooted expertise in key sectors including Funds, Capital Markets, Public, Mobility, Energy and Healthcare. For international transactions and projects, we work together with selected reputable law firms abroad. Our advice combines an economic focus with entrepreneurial foresight. That is what is behind: Your perspective. More about us: www.gsk.de

Commercial law firm GSK Stockmann successfully advised Pembroke Real Estate on the acquisition of a high-profile development site located on Alramstrasse in Munich’s Sendling district. The highly complex and time-sensitive transaction involved not only the conclusion of a share and asset deal, but also numerous accompanying agreements and negotiations with multiple parties. The acquisition marks Pembroke Real Estate’s first foray into the German real estate market. The international real estate firm has already acquired multiple high-end commercial properties in Munich and Hamburg. An experienced GSK Stockmann team led by partners Volker Hofstetter (Real Estate, Frankfurt) and Marcel Vietor (Corporate, Munich) provided Pembroke Real Estate with comprehensive legal advice to ensure a smooth transaction process. The successful completion of this complex transaction in such a short timeframe is a testament to the firm’s 360-degree advisory approach, which creates added value for its clients through interdisciplinary and innovative solutions and an in-depth understanding of the legal and economic requirements for these kinds of transactions, even during challenging market phases. Advisers of Pembroke Real Estate at GSK Stockmann: Volker Hofstetter (lead, Partner, Real Estate), Dr Marcel Vietor (lead, Partner, Corporate); Andreas Dimmling (Partner, Insolvency & Restructuring); Dr Alma Franke (Partner, Finance); Dr Maximilian Schilling (Partner, Construction Law); Dr Mark Butt (Partner, Public & Planning Law); Dr Timo Bernau (Partner, Regulatory); Jan Kramer (Local Partner, Construction Law); Dr Katharina Odermatt (Local Partner, Real Estate); Felix Bergfort (Local Partner, Real Estate); Dr Mechthild Maria Siebke (Local Partner, Finance); Dominik Berka (Local Partner, Tax); Dr Uta Birk, David Hansen, Claudia Maria Laszuk, Karolin Streser (Associates, Real Estate); Andrea Nowak (Associate, Corporate); Marcel Buss (Associate, Finance); Iryna Stefak (Associate, Construction Law); Leonie Lindenbuß (Associate, Public & Planning Law); Dr Martin Freytag and Nicole Habersetzer (Associates, Regulatory). ### Contact: GSK STOCKMANN Volker Hofstetter Bockenheimer Landstr. 24 60323 Frankfurt am Main T +49 69 710003 - 137 F +49 69 710003-144 [email protected] Press contact: GSK STOCKMANN Christina Holl Karl-Scharnagl-Ring 8 80539 Munich T +49 89 288174-275 F +49 89 288 174-44 [email protected] GSK Stockmann is a leading independent European corporate law firm. Over 250 professionals advise German and international clients at our locations in Berlin, Frankfurt/M., Hamburg, Heidelberg, Munich, Luxembourg and London. GSK is the law firm of choice for Real Estate and Financial Services. We also have deep-rooted expertise in key sectors including Funds, Capital Markets, Public, Mobility, Energy and Healthcare. For international transactions and projects, we work together with selected reputable law firms abroad. Our advice combines an economic focus with entrepreneurial foresight. That is what is behind: Your perspective. More about us: www.gsk.de

GSK Stockmann advised DZ HYP AG on the financing of the Upper West high-rise building in Berlin-Charlottenburg. The buyer is Schoeller Group GmbH, based in Pullach near Munich. Upper West is located directly on Berlin’s Breitscheidplatz, opposite Kaiser Wilhelm Memorial Church and just a stone’s throw from the city’s famous shopping boulevard, Kurfürstendamm. At around 120 metres high, it is one of the tallest buildings in Berlin. The building’s distinctive glass and steel façade makes it a striking part of the city’s skyline. The building also meets high standards in terms of urban development and sustainability. Upper West combines office and retail space, as well as a Motel One flagship hotel with 582 rooms over 19 floors. The building is DGNB Gold & LEED Platinum certified. A GSK Stockmann team led by Munich partner Alma Franke advised DZ HYP on financing the purchase transaction. Advisers of DZ HYP AG at GSK Stockmann: Dr Alma Franke (lead), Dr Mechtild-Maria Siebke, Marcel Buss, Beatrice Christina Dörr (all finance), Robert Korndörfer, Dr Raoul Kreide, Matti Kamer (both corporate), Stefan Schlapka (real estate law/hospitality), Andreas Heinzmann, Hawa Mahamoud, Eva Jean (corporate/finance, Luxembourg)

Labour and social security law expert Daniel Nerl has joined GSK Stockmann’s team in Luxembourg as local partner, where he will develop the firm’s new practice in that area. He joins from leading independent business and litigation law firm Kleyr Grasso – together with his Associate Julie Tisserand – and will work closely together with Counsel Marie-Therese Wich. Daniel Nerl has extensive experience in the fields of labour and social security matters. He has been advising clients since 2011 on the entire spectrum of human resources matters by offering a full-service approach from advisory on day-to-day matters (including on- and offboarding, due diligences, general corporate support, etc.) to litigation. In addition, he has been a lecturer for training organisms on HR matters for over 10 years. Daniel Nerl studied in France in Bordeaux and Paris at the Sorbonne and was admitted to the bar in Luxembourg in 2011; he is member of ELSA asbl – Employment Law Specialist Association Luxembourg. “We are pleased to welcome Daniel Nerl and Julie Tisserand to our team. Their strong experience in the field of labour law and litigation as well as their deep expertise of the Luxembourg market will benefit our international client base”, comments Andreas Heinzmann, Partner at GSK Stockmann in Luxembourg. “We are looking forward to working with the new team members who will further strengthen our international capabilities in labour law and litigation. We wish them a great start at GSK Stockmann”, adds Dr. Oliver Glück, Co-Managing Partner at GSK Stockmann. “I am thrilled to join GSK Stockmann in Luxembourg, together with my long-term colleague Julie Tisserand, and am looking forward to working with a strong team on challenging and complex projects”, says Daniel Nerl. The office of GSK Stockmann in Luxembourg opened in 2016 with four partners and has since grown to a team of more than 30 fee earners focussing on the field of Banking & Finance, Capital Markets, Corporate and M&A, Private Equity, Investment Funds, Real Estate, Regulatory, Insurance, and Tax. Press contact: GSK STOCKMANN Christina Holl Karl-Scharnagl-Ring 8 80539 Munich T +49 89 288174-275 F +49 89 288 174-44 [email protected] GSK Stockmann is a leading independent European corporate law firm. Over 250 professionals advise German and international clients at our locations in Berlin, Frankfurt/M., Hamburg, Heidelberg, Munich, Luxembourg and London. GSK is the law firm of choice for Real Estate and Financial Services. We also have deep-rooted expertise in key sectors including Funds, Capital Markets, Public, Mobility, Energy and Healthcare. For international transactions and projects, we work together with selected reputable law firms abroad. Our advice combines an economic focus with entrepreneurial foresight. That is what is behind: Your perspective. More about us: www.gsk.de

GSK Stockmann, working with a team of other firms including Troutman Pepper Locke, advised global digital infrastructure company Colt Technology Services on the sale of six of its data centres to NorthC, a data centre operator headquartered in the Netherlands. As part of the deal, Colt will also divest two of its other data centres in London to NorthC’s majority owner DWS Group. The eight data centres included in the transaction are in Amsterdam, Berlin, ‎Düsseldorf, Frankfurt, Hamburg and Munich, as well as the two in London. The data centres were part of the ‎assets Colt gained with its acquisition of Lumen EMEA in 2023. GSK Stockmann, working with Troutman Pepper Locke and a team of further local counsel and instructed by Nadine Ramasamy, Alex Galtieri and Annarita Spena of Colt, advised on the German real estate aspects of the deal and also on Colt’s ongoing partnership with NorthC. Colt’s future relationship with NorthC will include Colt retaining network equipment in the divested data centres as part of its global digital ‎infrastructure, which connects 32,000 buildings, spans more than 40 countries, reaches more than 275 ‎points of presence, and includes 10 subsea cable systems‎. The transaction is expected to close in summer 2025. [caption id="attachment_48296" align="alignnone" width="300"] GSK Berlin[/caption] Advisers of Colt at GSK Stockmann: Dr Olaf Schmechel (lead partner, Real Estate/Data Centres), Çağlayan Birkan (Real Estate), Sören Wolkenhauer (Energy), Dr Jörg Kahler (IP/IT), Dr Anna Charlotte Kümpers (Public Law) Contact: GSK STOCKMANN Dr Olaf Schmechel Mohrenstrasse 42 10117 Berlin T +49 30 203907 - 0 F +49 30 203907-44 [email protected] Press contact: GSK STOCKMANN Christina Holl Karl-Scharnagl-Ring 8 80539 Munich T +49 89 288174-275 F +49 89 288 174-44 [email protected] GSK Stockmann is a leading independent European corporate law firm. Over 250 professionals advise German and international clients at our locations in Berlin, Frankfurt/M., Hamburg, Heidelberg, Munich, Luxembourg and London. GSK is the law firm of choice for Real Estate and Financial Services. We also have deep-rooted expertise in key sectors including Funds, Capital Markets, Public, Mobility, Energy and Healthcare. For international transactions and projects, we work together with selected reputable law firms abroad. Our advice combines an economic focus with entrepreneurial foresight. That is what is behind:  Your perspective. More about us: www.gsk.de/en

GSK Stockmann has provided comprehensive legal advice to L-Rea GmbH on the establishment of a joint venture with the BlueRock Group AG regarding L-Rea GmbH’s subsidiary Residea Immobilien Management GmbH. Since April, the BlueRock Group AG, based in Zurich and Berlin, holds a stake in Residea Immobilien Management GmbH as part of a joint venture. A team led by Berlin based partner and Corporate/M&A specialist Dr. Thomas Derlin provided comprehensive legal support to L-Rea GmbH regarding this strategic partnership with BlueRock Group AG, in particular in the negotiations and conclusion of the share purchase agreement and the joint venture agreement as well as related corporate and commercial law issues. Residea Immobilien Management GmbH is a fully integrated asset management company, managing a portfolio of several thousand residential and commercial units, primarily in Berlin. For the real estate investor and asset manager BlueRock Group AG, the participation secures access to qualified management capacities in the demanding Berlin real estate market. [caption id="attachment_48294" align="alignnone" width="300"] GSK Berlin[/caption] Advisers of L-Rea at GSK Stockmann: Dr Thomas Derlin, Dr Andreas C. Peters (both lead, both Corporate/M&A), Dominik Berka (Tax), Jan Kramer (Real Estate) Christina Lorf (Corporate/M&A) Advisers of Blue Rock Group: Heussen Rechtsanwaltsgesellschaft mbH: Jan Dittmann, Johannes Weidelener Notary: Heuking Contact: GSK STOCKMANN Dr Thomas Derlin Mohrenstrasse 42 10117 Berlin T +49 30 203907 - 0 F +49 30 203907-44 [email protected] Press contact: GSK STOCKMANN Christina Holl Karl-Scharnagl-Ring 8 80539 Munich T +49 89 288174-275 F +49 89 288 174-44 [email protected] GSK Stockmann is a leading independent European corporate law firm. Over 250 professionals advise German and international clients at our locations in Berlin, Frankfurt/M., Hamburg, Heidelberg, Munich, Luxembourg and London. GSK is the law firm of choice for Real Estate and Financial Services. We also have deep-rooted expertise in key sectors including Funds, Capital Markets, Public, Mobility, Energy and Healthcare. For international transactions and projects, we work together with selected reputable law firms abroad. Our advice combines an economic focus with entrepreneurial foresight. That is what is behind:  Your perspective. More about us: www.gsk.de/en

GSK Stockmann advised the fintech company Eleving Group on the completion of the largest offer of shares by way of an initial public offering (IPO) of a privately held company in Latvia and subsequent listing and trading of the offered shares on the Nasdaq Baltic Main List and Frankfurt Stock Exchange’s regulated market Prime Standard. With the IPO, Eleving Group aims to offer investors an opportunity to invest in one of the fastest growing, Baltic-headquartered, and Luxembourg-domiciled fintech companies operating in vehicle and consumer financing segments across 16 markets and three continents. The GSK Stockmann team from Luxembourg, led by Andreas Heinzmann, provided comprehensive legal advice to Eleving including the drafting of the prospectus, the share capital increase and the dual listing of the shares on the Frankfurt Stock Exchange´s regulated market and on the Nasdaq Baltic main list. Eleving Group has driven innovation in financial technology around the world since its foundation in Latvia in 2012. As of today, the group operates in 16 markets and three continents, encouraging financial inclusion and upward social mobility in underserved communities around the globe. Eleving Group has developed a multi-brand portfolio for its vehicle and consumer finance business lines, with around 2/3 of the portfolio comprising secured vehicle loans and mobility products, with Mogo as the leading brand, and around 1/3 of the portfolio including unsecured consumer finance products, with Kredo and Tigo as the segment’s flagship brands. Currently, 55 % of the group’s portfolio is located in Europe, 32 % in Africa, and 13 % in the rest of the world. The following GSK Stockmann team advised Eleving: Andreas Heinzmann (Lead Partner – Banking, Finance and Capital Markets | Luxembourg), Hawa Mahamoud (Senior Associate – Banking, Finance and Capital Markets | Luxembourg), Katharina Schramm (Senior Associate – Banking, Finance and Capital Markets | Luxembourg), Eva Jean (Associate – Banking, Finance and Capital Markets | Luxembourg), Chara Papagiannidi (Senior Associate – Corporate and Capital Markets | Luxembourg), Dr. Alexander Thomas (Partner – Corporate and Capital Markets | Munich), Anna Gassner (Partner – Corporate and M&A | Luxembourg), Mathilde Ostertag (Partner –Tax | Luxembourg), Adrien Kleinschmidt (Senior Associate – Tax | Luxembourg), Dominik Berka (Local Partner – Tax | Frankfurt)

Based on the successful partnership agreement between GSK Stockmann and the Brexit Institute since 2020, GSK Stockmann will continue to sponsor the activities of the Institute in the field of European affairs for three more years – until 2027. The partnership agreement was extended in light of a number of important developments in relation to EU financial and economic affairs. Valerio Scollo, Partner at GSK Stockmann in Luxembourg, comments: “GSK Stockmann is pleased about the extension of the partnership agreement with the Brexit Institute providing insights on the future of the European Union. Situated in the heart of Europe, the Luxembourg office of GSK Stockmann is ideally positioned to support the activities of the Brexit Institute.” Professor Federico Fabbrini, Full Professor of EU Law and Founding Director of the Brexit Institute says: “As the Brexit Institute steadily expands its remit – as visible with the recent establishment of the Dublin European Law Institute – and secures new EU research projects – notably a major Jean Monnet Network – we are delighted to continue the fruitful and enriching cooperation with a leading European law firm like GSK Stockmann.” Given the multifaceted legal, political and economic implications of Brexit, Dublin City University (DCU) has established the Brexit Institute with the aim to explore how Brexit impacts on government, business and society at large. The DCU Brexit Institute operates as a hub and a magnet for the analysis of Brexit, both from an academic and a policy perspective. Through the organization of regular events the Brexit Institute provides a leading platform to document and debate developments in the relations between the UK and the EU. GSK Stockmann is a leading European law firm with offices in Germany, Luxembourg and the UK. Since its opening in 2016, the Luxembourg office of GSK Stockmann has grown significantly. With Luxembourg being situated at the centre of Europe and being the home of numerous EU institutions, GSK Stockmann is the trusted advisor of leading financial institutions, asset managers, private equity houses, insurance companies, corporates and FinTech companies, with both a local and international reach.

TopLegal – one of Italy’s leading legal publications – recognized GSK Stockmann as “Italian Desk independente dell’anno” (“Independent Italian Desk of the year”) at the TopLegal Awards 2024 in Milan. The TopLegal Awards were initiated in 2007 providing law and tax firms a platform to present their skills and quality in the context of advising and assisting clients – taking place on an annual basis. The criteria include client service, innovation, specific sector knowledge and client solutions. The TopLegal Awards reward both, teams and individual professionals. The full list of winners of the TopLegal Awards 2024 is available here. Valerio Scollo, Partner at GSK Stockmann and co-head of the GSK Desk Italy, says: “We are delighted that our work is recognized by the TopLegal Awards 2024 in the category “Italian Desk – independent law firm of the year”. Winning the award underlines GSK Stockmann’s ongoing growth and development of the firm’s international activities as a leading independent firm in Europe”. GSK Stockmann has bundled its many years of international activities into country desks – GSK Desks – to serve its clients’ global requirements, providing seamless German and Luxembourg law services out of its offices in Germany, Luxembourg and the UK.  

At the prestigious The Lawyer European Awards 2024 in London, GSK Stockmann has been named “Law Firm of the Year for Benelux”. In addition, the firm received the recognition “commended” in the category “Law Firm of the Year for Germany” and was “shortlisted” in the category “European Law Firm of the Year”. The Lawyer European Awards are aimed at leading law firms based within Europe. Each category has specific criteria and the awards are open to independent law firms headquartered in Europe and global firms working within the European market. The awards incorporate country and region-specific awards categories. They were the first Awards established to celebrate excellence across the European legal market. The awards jury explains the decision behind naming GSK Stockmann “Law firm of the Year for Benelux” with the following statement: “The winning firm in this category distinguished itself through its impressive client list and an emphasis on strategic growth and international reach. Showcasing a balanced performance with notable ESG and D&I efforts, together with a strong focus on key markets such as investment funds and real estate finance.” “Congratulations to all of this year’s winners, as well as to those who were commended or shortlisted. A sincere thanks goes to all clients and peers for their continued trust and endorsements. We are proud of our strengthened international visibility and to have such excellent teams across our offices in Luxembourg, London and Germany. Many thanks to all at GSK Stockmann for their hard work and dedication: We will continue to write our success story”, comments Dr. Oliver Glück, Co-Managing Partner at GSK Stockmann in Germany. Andreas Heinzmann, International Partner at GSK Stockmann in Luxembourg, adds: “We are delighted about the firm’s results at the awards ceremony in London. Winning the award underlines the strong local presence and the ongoing strategic growth and development of GSK Stockmann coupled with a clear focus on cross-border activities across the firm’s offices in Germany, Luxembourg and London.” This year, a total of 27 awards were handed out over the course of the evening. Winners were named in a range of categories focused on particular jurisdictions, practice groups, initiatives as well as individual awards for the year’s outstanding general counsel or managing partner. Further information about this year’s The Lawyer European Awards and the full list of winners is available here.

GSK Stockmann in Luxembourg was again recognized as Great Place to Work® for December 2024-December 2025 based on an extensive anonymous online survey with 69 questions conducted by the Great Place to Work® Institute. As a result of the study, the trust index shows that 80 % of the team members say that GSK Stockmann in Luxembourg is a Great Place to Work®. As the global authority on workplace culture, Great Place To Work® brings 30 years of groundbreaking research and data to help every place become a great place to work for all. Their proprietary platform and For All™ Model helps companies evaluate the experience of every employee, with exemplary workplaces becoming Great Place To Work Certified™ or receiving recognition on a coveted Best Workplaces™ List. The Great Place To Work® Certification™ is the most definitive “employer-of-choice” recognition that companies aspire to achieve. It is the only recognition based entirely on what employees report about their workplace experience – specifically, how consistently they experience a high-trust workplace. Great Place to Work Certification is recognized worldwide by employees and employers alike and is the global benchmark for identifying and recognizing outstanding employee experience. Every year, more than 10,000 companies across 60 countries apply to get Great Place To Work-Certified. “We are proud to earn for the third time The Great Place to Work® Certification™ which is based on the positive feedback from our lawyers and employees alike and shows that our firm is a true collaborative and positive environment that emphasizes the importance of wellbeing. This recognition underlines our successful development combined with our strong focus on firm culture and values. Therefore, we would like to thank our entire team for contributing to establish a Great Place to Work®”, says Dr. Manuel Fernandez, Partner in charge of HR at GSK Stockmann in Luxembourg. Further information regarding the Great Place to Work® certification can be found on the following website: https://www.greatplacetowork.lu/fr/certification/profils/gsk-stockmann

Legalcommunity – one of the largest legal media in Southern Europe for business lawyers, tax lawyers and accountants – awarded GSK Stockmann in the category “Italian Desk” at the Legalcommunity Finance Awards 2025. The Legalcommunity Awards are widely regarded as one of the most important Italian awards in the sector, recognizing excellence in the legal market. Valerio Scollo, Partner at GSK Stockmann and co-head of the GSK Desk Italy, says: “We are thrilled that our work is recognized by the Legalcommunity Finance Awards 2025 in the category “Italian Desk”. Winning the award underlines GSK Stockmann’s ongoing growth and development of the firm’s international activities, in particular of the GSK Desk Italy and the Finance practice.” Legalcommunity Publishing Group explains the award: “The European law firm boasts a strong team of 15 lawyers dedicated to the Italian desk, who have handled numerous cross-border transactions. Among these, their assistance to a well-known Italian telecommunications operator in a multi-billion-euro deal stands out.” In 2022, GSK Stockmann was named “Best Practice Italian Desk” at the Legalcommunity Real Estate Awards; the full list of winners of the Legalcommunity Finance Awards 2025 is available here.  

The commercial law firm advised handly GmbH from Berlin on a series-seed financing round. The EUR 3.75 million round was led by Stride Capital and 20VC. In addition to Stride Capital and 20VC, Base10 Partners, The Delta Flow, Angel Invest, Foreword and N & V Capital, as well as business angels such as JC Glancy and Ershad Jamil were involved in the round. The advice provided included assisting handly in the due diligence process and negotiating the contractual documentation for the financing round, as well as providing legal support in the implementation of pre-structuring measures prior to the financing round. Software-as-a-Service provider (SaaS) handly offers a platform for company management. The service is aimed at craft businesses and provides support in setting up and efficiently managing business operations. Advisers of handly GmbH at GSK Stockmann: Katy Ritzmann (lead), Clara López Hernando, Dennis Gehnen, (both PE/VC), Nicole Deparade (employment law) Other advisers: For 20 VC and Stride.VC: GreenGate Partners Rechtsanwaltsgesellschaft mbH & Co. KG  

GSK Stockmann hat die AXA IM Alts / ACCUMULATA bei der Vermietung von rund 4.800 qm Bürofläche im Münchner Bauprojekt „The Stack“ an die Novartis Pharma GmbH beraten. Auf Seiten von GSK Stockmann wurde ein Team rund um die Münchner Partnerin Monique Franke tätig. GSK Stockmann berät den Vermieter umfassend bei der Projektentwicklung und der Vermietung einschließlich der Entwicklung des Konzeptes der modernen Arbeitswelten. Das „The Stack“ ist ein innovatives Holz-Hybrid-Gebäude mit einer begrünten Fassade, welches großen Wert auf Nachhaltigkeit und Nutzerkomfort legt. Es entsteht an der Ecke Goethestraße/ Schwanthalerstraße im südlichen Münchner Bahnhofsviertel. Das Gebäude wird rund 17.000 qm Mietfläche umfassen und bietet großzügige Gemeinschaftsflächen im Erdgeschoss sowie dem Dachgarten. Die Fertigstellung des Projekts ist für Anfang 2026 geplant. Berater GSK Stockmann für AXA IM Alts / ACCUMULATA Monique Franke (Federführung), Dr. Nadine Wachendorf, Katharina Groche (alle: Immobilien-Asset-Management), Stephan Wachsmuth (Steuerrecht); Associates: Florian Pletschacher, Bianca Luppert (beide: Immobilien-Asset-Management) [caption id="attachment_47452" align="alignnone" width="1181"] GSK München[/caption]  

GSK Stockmann advised AXA IM Alts / ACCUMULATA on the letting of around 4,800 sqm of office space in the Munich building project “The Stack” to Novartis Pharma GmbH.  The GSK Stockmann team was led by Munich partner Monique Franke and advised the lessor comprehensively on project development and the lease, including on developing a concept of modern workplaces. The Stack is an innovative project under construction on the corner of Goethestrasse and Schwanthalerstrasse in Munich’s southern railway station district. Its timber­hybrid structure and green façade demonstrate the great emphasis on sustainability and living comfort. The building will offer around 17,000 sqm of rental space as well as generous communal areas on the ground floor and the roof garden. The project is scheduled for completion in early 2026.  Advisers of AXA IM Alts / ACCUMULATA at GSK Stockmann: Monique Franke (lead), Nadine Wachendorf, Katharina Groche (all: Real Estate Asset Management), Stephan Wachsmuth (Tax); Associates: Florian Pletschacher, Bianca Luppert (both: Real Estate Asset Management) [caption id="attachment_47448" align="alignnone" width="1181"] GSK München[/caption]  

A GSK Stockmann team led by Munich partner Stephan Wachsmuth advised Giesecke+Devrient Grundstücksgesellschaft mbH & Co. KG and DER bogen GmbH & Co. KG on the tax structuring of a new development project in Bogenhausen. The “DER bogen” business campus, located in the vicinity of the security and technology company Giesecke+Devrient GmbH in the east of Munich, has been under construction since spring 2020. GSK Stockmann provided comprehensive tax advice for the entire duration of the project. The team’s advice mainly focused on the tax implementation and structuring of an area that was previously part of the Giesecke+Devrient’s headquarters and is now to be used for the construction of “DER Bogen”, a real estate project with a total GFA of 43,000 sqm. GSK Stockmann provided support on a wide range of real estate tax issues, including income tax and real estate transfer tax, as well as procedural issues relating to real estate law and the associated contract drafting. The building complex on Prinzregentenstrasse is part of the technology hub in Munich’s Bogenhausen neighbourhood and should be ready for occupancy by the end of 2025. Advisers of Giesecke+Devrient Grundstücksgesellschaft mbH & Co. KG and DER bogen GmbH & Co. KG at GSK Stockmann: Dirk Koch (no longer at GSK), Stephan Wachsmuth (both lead, tax law), Sebastian Gerhards (tax law), Andreas Eichler, Katharina Feierabend (both real estate law)